DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys

Yu Ting Chang, Ching Chin Yang, Szu Yu Pan, Yu Hsiang Chou, Fan Chi Chang, Chun Fu Lai, Ming Hsuan Tsai, Huan Lun Hsu, Ching Hung Lin, Wen Chih Chiang, Ming Shiou Wu, Tzong Shinn Chu, Yung Ming Chen, Shuei Liong Lin

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patients with chronic kidney disease, but these cells do not produce sufficient erythropoietin in response to hypoxic stimuli. Treatment with HIF stabilizers rescues erythropoietin production in these cells, but the mechanisms underlying the decreased response of REPCs in fibrotic kidneys to anemic stimulation remain elusive. Here, we show that fibroblast-like FOXD1+ progenitor-derived kidney pericytes, which are characterized by the expression of α1 type I collagen and PDGFRβ, produce erythropoietin through HIF2α regulation but that production is repressed when these cells differentiate into myofibroblasts. DNA methyltransferases and erythropoietin hypermethylation are upregulated in myofibroblasts. Exposure of myofibroblasts to nanomolar concentrations of the demethylating agent 5-azacytidine increased basal expression and hypoxic induction of erythropoietin. Mechanistically, the profibrotic factor TGF-β1 induced hypermethylation and repression of erythropoietin in pericytes; these effects were prevented by 5-azacytidine treatment. These findings shed light on the molecular mechanisms underlying erythropoietin repression in kidney myofibroblasts and demonstrate that clinically relevant, nontoxic doses of 5-azacytidine can restore erythropoietin production and ameliorate anemia in the setting of kidney fibrosis in mice.

Original languageEnglish
Pages (from-to)721-731
Number of pages11
JournalJournal of Clinical Investigation
Volume126
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Methyltransferases
Erythropoietin
Kidney
DNA
Myofibroblasts
Azacitidine
Pericytes
Collagen Type I
Chronic Renal Insufficiency
Anemia
Fibrosis
Fibroblasts

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chang, Y. T., Yang, C. C., Pan, S. Y., Chou, Y. H., Chang, F. C., Lai, C. F., ... Lin, S. L. (2016). DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. Journal of Clinical Investigation, 126(2), 721-731. https://doi.org/10.1172/JCI82819

DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. / Chang, Yu Ting; Yang, Ching Chin; Pan, Szu Yu; Chou, Yu Hsiang; Chang, Fan Chi; Lai, Chun Fu; Tsai, Ming Hsuan; Hsu, Huan Lun; Lin, Ching Hung; Chiang, Wen Chih; Wu, Ming Shiou; Chu, Tzong Shinn; Chen, Yung Ming; Lin, Shuei Liong.

In: Journal of Clinical Investigation, Vol. 126, No. 2, 01.02.2016, p. 721-731.

Research output: Contribution to journalArticle

Chang, YT, Yang, CC, Pan, SY, Chou, YH, Chang, FC, Lai, CF, Tsai, MH, Hsu, HL, Lin, CH, Chiang, WC, Wu, MS, Chu, TS, Chen, YM & Lin, SL 2016, 'DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys', Journal of Clinical Investigation, vol. 126, no. 2, pp. 721-731. https://doi.org/10.1172/JCI82819
Chang, Yu Ting ; Yang, Ching Chin ; Pan, Szu Yu ; Chou, Yu Hsiang ; Chang, Fan Chi ; Lai, Chun Fu ; Tsai, Ming Hsuan ; Hsu, Huan Lun ; Lin, Ching Hung ; Chiang, Wen Chih ; Wu, Ming Shiou ; Chu, Tzong Shinn ; Chen, Yung Ming ; Lin, Shuei Liong. / DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. In: Journal of Clinical Investigation. 2016 ; Vol. 126, No. 2. pp. 721-731.
@article{1b407f3f1523493ba94a7db46ba66543,
title = "DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys",
abstract = "Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patients with chronic kidney disease, but these cells do not produce sufficient erythropoietin in response to hypoxic stimuli. Treatment with HIF stabilizers rescues erythropoietin production in these cells, but the mechanisms underlying the decreased response of REPCs in fibrotic kidneys to anemic stimulation remain elusive. Here, we show that fibroblast-like FOXD1+ progenitor-derived kidney pericytes, which are characterized by the expression of α1 type I collagen and PDGFRβ, produce erythropoietin through HIF2α regulation but that production is repressed when these cells differentiate into myofibroblasts. DNA methyltransferases and erythropoietin hypermethylation are upregulated in myofibroblasts. Exposure of myofibroblasts to nanomolar concentrations of the demethylating agent 5-azacytidine increased basal expression and hypoxic induction of erythropoietin. Mechanistically, the profibrotic factor TGF-β1 induced hypermethylation and repression of erythropoietin in pericytes; these effects were prevented by 5-azacytidine treatment. These findings shed light on the molecular mechanisms underlying erythropoietin repression in kidney myofibroblasts and demonstrate that clinically relevant, nontoxic doses of 5-azacytidine can restore erythropoietin production and ameliorate anemia in the setting of kidney fibrosis in mice.",
author = "Chang, {Yu Ting} and Yang, {Ching Chin} and Pan, {Szu Yu} and Chou, {Yu Hsiang} and Chang, {Fan Chi} and Lai, {Chun Fu} and Tsai, {Ming Hsuan} and Hsu, {Huan Lun} and Lin, {Ching Hung} and Chiang, {Wen Chih} and Wu, {Ming Shiou} and Chu, {Tzong Shinn} and Chen, {Yung Ming} and Lin, {Shuei Liong}",
year = "2016",
month = "2",
day = "1",
doi = "10.1172/JCI82819",
language = "English",
volume = "126",
pages = "721--731",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys

AU - Chang, Yu Ting

AU - Yang, Ching Chin

AU - Pan, Szu Yu

AU - Chou, Yu Hsiang

AU - Chang, Fan Chi

AU - Lai, Chun Fu

AU - Tsai, Ming Hsuan

AU - Hsu, Huan Lun

AU - Lin, Ching Hung

AU - Chiang, Wen Chih

AU - Wu, Ming Shiou

AU - Chu, Tzong Shinn

AU - Chen, Yung Ming

AU - Lin, Shuei Liong

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patients with chronic kidney disease, but these cells do not produce sufficient erythropoietin in response to hypoxic stimuli. Treatment with HIF stabilizers rescues erythropoietin production in these cells, but the mechanisms underlying the decreased response of REPCs in fibrotic kidneys to anemic stimulation remain elusive. Here, we show that fibroblast-like FOXD1+ progenitor-derived kidney pericytes, which are characterized by the expression of α1 type I collagen and PDGFRβ, produce erythropoietin through HIF2α regulation but that production is repressed when these cells differentiate into myofibroblasts. DNA methyltransferases and erythropoietin hypermethylation are upregulated in myofibroblasts. Exposure of myofibroblasts to nanomolar concentrations of the demethylating agent 5-azacytidine increased basal expression and hypoxic induction of erythropoietin. Mechanistically, the profibrotic factor TGF-β1 induced hypermethylation and repression of erythropoietin in pericytes; these effects were prevented by 5-azacytidine treatment. These findings shed light on the molecular mechanisms underlying erythropoietin repression in kidney myofibroblasts and demonstrate that clinically relevant, nontoxic doses of 5-azacytidine can restore erythropoietin production and ameliorate anemia in the setting of kidney fibrosis in mice.

AB - Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patients with chronic kidney disease, but these cells do not produce sufficient erythropoietin in response to hypoxic stimuli. Treatment with HIF stabilizers rescues erythropoietin production in these cells, but the mechanisms underlying the decreased response of REPCs in fibrotic kidneys to anemic stimulation remain elusive. Here, we show that fibroblast-like FOXD1+ progenitor-derived kidney pericytes, which are characterized by the expression of α1 type I collagen and PDGFRβ, produce erythropoietin through HIF2α regulation but that production is repressed when these cells differentiate into myofibroblasts. DNA methyltransferases and erythropoietin hypermethylation are upregulated in myofibroblasts. Exposure of myofibroblasts to nanomolar concentrations of the demethylating agent 5-azacytidine increased basal expression and hypoxic induction of erythropoietin. Mechanistically, the profibrotic factor TGF-β1 induced hypermethylation and repression of erythropoietin in pericytes; these effects were prevented by 5-azacytidine treatment. These findings shed light on the molecular mechanisms underlying erythropoietin repression in kidney myofibroblasts and demonstrate that clinically relevant, nontoxic doses of 5-azacytidine can restore erythropoietin production and ameliorate anemia in the setting of kidney fibrosis in mice.

UR - http://www.scopus.com/inward/record.url?scp=84956934760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956934760&partnerID=8YFLogxK

U2 - 10.1172/JCI82819

DO - 10.1172/JCI82819

M3 - Article

C2 - 26731474

AN - SCOPUS:84956934760

VL - 126

SP - 721

EP - 731

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -